| Net Cash Provided by (Used in) Operating Activities |
-30K |
USD |
-115% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
3.48M |
shares |
+1.53% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-30K |
USD |
-115% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
10.6M |
USD |
+3.17% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
311K |
USD |
+11.5% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
446K |
USD |
+62.8% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
2.54M |
USD |
-3.16% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
41K |
USD |
+116% |
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
23K |
USD |
-4.17% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
532K |
USD |
+39.3% |
Q4 2024 |
FY 2024 |